BrainStorm to Participate in BIO Digital 2020
(World News Science)

PDF Version Management to Host One-on-One Partnering Meetings NEW YORK, June 3, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced Dr. Ralph Kern, M.D, President and Chief Medical Officer will present a corporate overview during the BIO International Convention, which has transitioned to a new and virtual event and has been renamed BIO Digital. During BIO Digital, Dr. Kern will update conference participants on the Company`s investigational therapeutic NurOwn® that is currently in a phase 3 study for the treatment of ALS and a phase 2 study for the treatment of progressive...